BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22.04.2004

Critical Path Initiative; Establishment of Docket

The Food and Drug Administration (FDA) is establishing a public docket to obtain input on activities that could reduce existing hurdles in medical product design and development. As described in a recently released Report, "Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products," there is an urgent need to modernize the product development toolkit, to make the development process more predictable and less costly. FDA is seeking input in identifying and prioritizing the most pressing medical product development problems, and the areas that provide the greatest opportunities for rapid improvement and public health benefits. To this end, we are establishing this open docket to obtain input from industry, patients, academics investors, and all interested parties.

Source: Federal Register — Food and Drug AdministrationOpen original release →